Zomedica Corp (ZOM)
| Sector • Healthcare Industry • Major Pharmaceutical Preparations |
| Industry • Major Pharmaceutical Preparations |
| Sector • Healthcare |
Robust 46.148% Top-line rise at ZOM in the January to March 31 2023 time-frame
ZOM delivered first quarter of 2023 operating shortfall of $-7.512 million
Published 2023-05-14T04:11:53+00:00
Goran Soko / CSIMarket.com Contributer
The Major Pharmaceutical Preparations company increased a shortfall per share at $-0.01 per share in the January to March 31 2023 time-frame, although its revenue surged by 46.148 % to $5.48 million from the corresponding quarter a year before. In the previous quarter the company realized Revenue of $6.16 million and $0.00 per share.
For the first quarter of 2023 earnings season Zomedica Corp realized net shortfall of $-6.385 million, higher than $-3.937 million a year ago.
Zomedica Corp is expected to report next financial recent numbers on August 14, 2023.
Other ZOM's Earnings Reports
Zomedica reported Q4 of 2022 earnings
Other ZOM's Earnings Reports
Zomedica reported Q4 of 2022 earnings